C11ORF57 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.859210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.723830E-01
Normal-vs-Stage2
1.913610E-01
Normal-vs-Stage3
2.104300E-02
Normal-vs-Stage4
9.566800E-01
Stage1-vs-Stage2
9.400000E-01
Stage1-vs-Stage3
1.146410E-01
Stage1-vs-Stage4
3.089400E-01
Stage2-vs-Stage3
1.376000E-01
Stage2-vs-Stage4
1.141370E-01
Stage3-vs-Stage4
1.132600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.829360E-01
Normal-vs-AfricanAmerican
4.586600E-01
Normal-vs-Asian
1.374750E-01
Caucasian-vs-AfricanAmerican
4.414600E-01
Caucasian-vs-Asian
4.186600E-01
AfricanAmerican-vs-Asian
2.804600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.443160E-01
Normal-vs-Female
2.617400E-01
Male-vs-Female
1.200360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.012300E-02
Normal-vs-Age(41-60Yrs)
3.706800E-01
Normal-vs-Age(61-80Yrs)
1.489040E-01
Normal-vs-Age(81-100Yrs)
9.875900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.125700E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.969800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.728000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.461400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.269600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.192000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.105900E-02
Normal-vs-Daily Drinker
3.002800E-01
Normal-vs-Weekly Drinker
7.892000E-02
Normal-vs-Occasional Drinker
3.837000E-01
Normal-vs-Social Drinker
9.715500E-02
Non Drinker-vs-Daily Drinker
4.295600E-01
Non Drinker-vs-Weekly Drinker
9.091400E-01
Non Drinker-vs-Occasional Drinker
6.439800E-02
Non Drinker-vs-Social Drinker
1.273830E-01
Daily Drinker-vs-Weekly Drinker
4.817800E-01
Daily Drinker-vs-Occasional Drinker
4.825200E-01
Daily Drinker-vs-Social Drinker
6.882600E-01
Weekly Drinker-vs-Occasional Drinker
1.301170E-01
Weekly Drinker-vs-Social Drinker
1.746580E-01
Occasional Drinker-vs-Social Drinker
6.538000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.605620E-01
Normal-vs-Grade 2
3.615600E-02
Normal-vs-Grade 3
5.663600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.629700E-02
Grade 1-vs-Grade 3
4.164200E-02
Grade 1-vs-Grade 4
1.605620E-01
Grade 2-vs-Grade 3
6.843200E-01
Grade 2-vs-Grade 4
3.615600E-02
Grade 3-vs-Grade 4
5.663600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.970000E-02
Normal-vs-NonDiabetic
1.334590E-01
Diabetic-vs-NonDiabetic
1.709350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.093440E-01
Normal-vs-NoPancreatitis
1.294210E-01
Pancreatitis-vs-NoPancreatitis
7.248000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.614590E-01
Normal-vs-N1
2.211600E-01
N0-vs-N1
9.017400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.252200E-01
Normal-vs-TP53-NonMutant
2.892400E-01
TP53-Mutant-vs-TP53-NonMutant
2.820400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
